Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

ABSTRACT: Study of NGM438 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors

DISEASE(S): Carcinoma,Cervical Cancer,Melanoma,Colorectal Cancer,Non Small Cell Lung Cancer,Mesothelioma,Pancreatic Cancer,Bladder Urothelial Cancer,Breast Cancer,Ovarian Cancer,Squamous Cell Carcinoma Of Head And Neck,Endocervical Cancer,Gastric Cancer,Esophageal Cancer,Carcinoma, Renal Cell,Prostate Cancer,Renal Cell Carcinoma,Cholangiocarcinoma

PROVIDER: 2717427 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR